Immune surveillance in multiple sclerosis patients treated with natalizumab

Abstract

These data suggest that natalizumab treatment results in a prolonged decrease of lymphocytes in the CSF and are consistent with the hypothesis that natalizumab impairs immune surveillance of the central nervous system.